Most commercial hops do not contain CBD. Independent laboratory analysis confirms that Kriya® Hops — a patented Humulus lupulus cultivar — does.
Botanically authenticated. Quantified by UPLC. THC not detected.
Commercial brewing hops do not express measurable cannabidiol (CBD).
Kriya® Hops is a selectively bred cultivar verified to contain 5.4% CBD with no detectable THC.
Monoclonal female brewing cultivars
Selected for lupulin, not cannabinoids
Asexually propagated clones
No active cannabinoid synthase pathway
Feral Humulus genetic diversity
Selection for CBD synthase expression
Absence of THC synthase
Stabilization prior to patent filing (2018 material = 5.4% CBD)
Cannabinoid Quantification (UPLC – 5.4% CBD, THC ND)
Hop-Specific Prenylflavonoids (0.417% total)
Commercial brewing hops do not contain measurable CBD. They are monoclonal female cultivars optimized for lupulin production.
Kriya® Hops is a patented cultivar selectively bred from rare feral Humulus populations expressing cannabinoid biosynthesis traits. Independent laboratory analysis of the 2018 patent-era material confirmed 5.4% cannabidiol (CBD)with no detectable THC.
Three independent analytical confirmations were performed on the same lot (04179102):
Prenylflavonoids such as:
are characteristic compounds of Humulus.
The Kriya® samples contained 0.417% total prenylflavonoids.
No.
Independent UPLC analysis showed Δ9-THC not detected in the Kriya® Hops samples.
Because nearly all commercial hops worldwide are brewing clones that do not express cannabinoid pathways.
Kriya® Hops is a selectively bred patented cultivar developed from rare feral Humulus expressing cannabinoid biosynthesis genes. It is the exception — not the rule.
Commercial brewing hops do not contain measurable CBD. They are monoclonal female cultivars optimized for lupulin production.
Kriya® Hops is a patented cultivar selectively bred from rare feral Humulus populations expressing cannabinoid biosynthesis traits. Independent laboratory analysis of the 2018 patent-era material confirmed 5.4% cannabidiol (CBD)with no detectable THC.
Three independent analytical confirmations were performed on the same lot (04179102):
Prenylflavonoids such as:
are characteristic compounds of Humulus.
The Kriya® samples contained 0.417% total prenylflavonoids.
No.
Independent UPLC analysis showed Δ9-THC not detected in the Kriya® Hops samples.
Because nearly all commercial hops worldwide are brewing clones that do not express cannabinoid pathways.
Kriya® Hops is a selectively bred patented cultivar developed from rare feral Humulus expressing cannabinoid biosynthesis genes. It is the exception — not the rule.
Humulus (hops) and Cannabis belong to the botanical family Cannabaceae. While cannabinoid biosynthesis is widely documented in Cannabis sativa, most modern commercial hop cultivars have been selectively bred for brewing characteristics rather than secondary metabolite diversity. As a result, contemporary brewing hops do not express measurable cannabidiol (CBD). However, genetic proximity within the Cannabaceae family means that biosynthetic pathways share evolutionary ancestry. Under certain genetic conditions, expression of cannabinoid-related precursors can occur in non-cannabis members of the family.*
The Kriya® Hops cultivar was developed through classical Mendelian selection from rare feral Humulus populations demonstrating cannabinoid pathway traits. Selection criteria focused on plants expressing CBD synthase activity while lacking detectable Δ9-THC synthase expression. Through multi-generational breeding and stabilization, a consistent chemotype was achieved prior to the 2018 patent filing. Independent laboratory analysis of that stabilized material confirmed 5.4% cannabidiol (CBD) with no detectable THC, establishing reproducible expression of CBD within a non-cannabis Humulus cultivar.
The widespread belief that “hops do not contain CBD” is accurate when referring to commercial brewing cultivars, which represent the overwhelming majority of global hop production. These plants are monoclonal, female-propagated varieties optimized for lupulin chemistry rather than cannabinoid pathways. Scientific literature and public databases reflect this dominant agricultural reality. Kriya® Hops represents a selectively bred exception derived from genetically diverse feral lineages. As with many botanical advancements, category-level assumptions persist until documented exceptions are sufficiently published and indexed.
